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Methicillin-resistant Staphylococcus aureus (MRSA) is a global cause of both hospital
and community-acquired infection.This retrospective, observational study determined the
prevalence of MRSA carriers in cardiothoracic and neurological surgical patients presenting
to an outpatient preoperative assessment center in Columbus, OH. Aggressive skin and
soft-tissue infection may be caused by MRSA with potentially fatal complications. Cardio-
thoracic and neurological surgical patients are at high risk for surgical-site infection. Results
indicated that 4.25% of the sample carried MRSA and 25.25% carried methicillin-sensitive
S. aureus.
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INTRODUCTION
Increasing reports of antibiotic-resistant bacterial infection and
hospital-acquired infection suggest a need for improved hos-
pital surveillance of pathogenic bacteria. In particular, Staphy-
lococcus aureus (SA) deserves monitoring because of its viru-
lence and prevalence and because strains of methicillin-resistant
SA (MRSA) constitute a worldwide cause of both hospital and
community-acquired infection (1, 2).
Estimates report that between 30 and 50% of adults are col-
onized with SA during their lifetimes, and that these apparently
healthy carriers are responsible for much of the spread of the bac-
terium (3). There is no genetic difference between commensal
and virulent forms of SA, so carriers are at risk of transmit-
ting the pathogen to others and becoming infected themselves
through broken skin or mucosal barriers (3, 4). Adhesion-receptor
interactions allow for the spread of SA within the epithelium
and endothelium (3, 5, 6). Once bound to the host cell, SA is
phagocytized, limiting immune surveillance and certain antibiotic
mechanisms (3). Heptameric alpha-hemolysin toxin forms trans-
membrane pores in the host cell’s wall, and subsequent cell lysis
releases cell byproducts that trigger inflammatory cytokines (3, 7).
Depending on the site of infection, damage can result to cardiac,
vascular, neurological, respiratory, or other tissues (3). Untreated,
SA can be fatal (e.g., by causing pneumonia or sepsis) with the
overall SA mortality rate between 11 and 43% (3, 8).
In recent years, the proportion of MRSA infections to
methicillin-sensitive SA (MSSA) infections has substantially
increased (9). MRSA are strains of SA expressing the
staphylococcal cassette chromosome mec (SCCmec), a mobile
genetic element conferring resistance to methicillin and related
beta-lactam class antimicrobials via production of a mutated peni-
cillin binding protein (PBP) that has reduced drug binding affinity
(10). Due to the genetic mobility of the resistance factor, MRSA
can be contracted from contact with existing colonies and can be
developed de novo in individuals already carrying an SA geno-
type (11). Individuals infected with MRSA are more difficult to
treat than those with MSSA, and experience extended hospital
stays, worsened clinical outcomes, and larger hospital bills (2, 12,
13). Specifically, head and neck surgical patients infected with
MRSA had their hospital stays increased three-fold compared to
non-infected patients and incurred increased antibiotic costs of
approximately $3810 (12). Moreover, MRSA-induced soft-tissue
lesions create opportunistic environments for subsequent MRSA
infection, complicating treatment (14).
Methicillin-resistant SA was previously thought to be primarily
hospital-acquired, with risk factors including prior hospitaliza-
tion within the past 12 months, longer length of stay, a history of
surgery, and use of macrolide or levofloxacin (2, 15, 16). MRSA
transmission has become increasingly common in community
populations as well (9, 11, 17, 18). Risk factors for community-
acquired MRSA include homelessness, IV drug use, incarceration
(2, 15, 19, 20) and skin or soft-tissue infection, particularly if asso-
ciated with immunodeficiency (19, 21). Nevertheless, community-
acquired MRSA is now commonly seen in individuals lacking
any known risk factors, making monitoring, and prevention more
challenging (18).
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Several reports suggest early identification of incoming patient
carriers through improved MRSA screening. A trial of universal
screening concluded that 64% of infected patients were unknow-
ingly carrying MRSA (10). Compared to universal screening, tar-
geted screening may be preferable because it incurs lower hospital
costs without significantly undermining surveillance quality (2, 22,
23). Ahmad et al. (2) analyzed the prevalence of MRSA infection
within an almost-universal screening regimen (75%) compared to
25% screening. The study observed a decrease in MRSA detection
from 2.3 to 2% and inferred that targeted screening is a sufficient
alternative to universal screening.
The nares are a particularly common area for MRSA colo-
nization, and screening of the nares accounts for up to73% of
carrier detections (1). Identifying carriers early is vital for patients
undergoing surgery, as MRSA is a leading cause of surgical-site
infection (SSI) (22, 24). Patients undergoing cardiothoracic and
neurological surgery are at an elevated risk of developing SSIs
due to endogenous and hematogenous pathogen access to the
thoracic and cranial cavities, with SSIs from MRSA strongly cor-
relating with postoperative morbidity and mortality (22, 24–26).
In spite of these risks, cardiothoracic and neurological surgery
patients appear to be at a low risk for contracting MRSA. Jog
et al. (22) reported a MRSA prevalence of only 2.5% in cardio-
thoracic surgical patients within the United Kingdom. Such low
reported prevalence calls into question the need for preoperative
screening in these patient populations. This study documents the
prevalence of patients presenting preoperatively with community-
acquired MRSA prior to cardiothoracic or neurological surgery at
a large, urban research hospital. The purpose of the study was to
determine whether this population should be omitted from selec-
tive MRSA screening protocols due to a low reported prevalence
of MRSA.
MATERIALS AND METHODS
A retrospective, non-randomized, observational study was con-
ducted in patients 18 years of age or older presenting to an
outpatient preoperative assessment center for cardiothoracic or
neurological surgery at a large, urban research hospital.
During the preoperative assessment, a nasal swab test was per-
formed. Ames red dual swab kits were used to collect nasal swabs
from patients upon admission to the hospital. One swab was col-
lected per patient and transported to the laboratory within 2 h
of collection. Swabs were inoculated directly onto blood agar
plates and incubated for 48 h before being examined. Latex coag-
ulase testing was performed on all Staphylococcus-like colonies.
Cefoxitin and trehalose mannitol salt (TMS) media were added to
plates found to be beta-hemolytic, catalase-positive, and latex pos-
itive. Beta-hemolytic, catalase-positive, latex-negative plates also
received TMS and additionally were tested with pyrrolidonyl ary-
lamidase (PYR) for coagulase-negative Staphylococcus. Negative
coagulase test plates were re-incubated and subsequently retested.
Acidic, yellow colonies indicated the presence of SA on the
TMS plates. In plates with added Cefoxitin, SA colonies were
classified as methicillin-resistant (MRSA) if the cefoxitin zone
was≤21 mm, and methicillin-susceptible (MSSA) if the zone was
≥22 mm. Patients found to be carriers of either MSSA or MRSA
were treated with nasal mupirocin.
Data from the electronic record were collected on patients fit-
ting the inclusion criteria. Study personnel, as approved by the
IRB, collected the necessary data for the study via chart review. The
data analysis consisted of a percentage analysis of the prevalence
of positive MRSA patients.
RESULTS
A total of 400 patient charts were reviewed for MRSA and SA pos-
itivity, 61% were male and 39% were female. The mean age was
58 years (Table 1).
Of the 400 total patients, 17 were found to be colonized
with MRSA (4.25%). This corresponds to an MRSA prevalence
of42 per 1000 patients with a standard deviation of 4.03. The
95% confidence interval for the population rate of MRSA is
0.0267–0.067.
In the same 400 patients, 101 were found to be positive for SA
colonies, so the sampled percentage of SA-positive patients was
101/400 or 25.25%. This corresponds to SA prevalence of 250 per
1000 patients, with a standard deviation of 8.68. The 95% con-
fidence interval for the population rate of SA is 0.2124–0.2973
(Figure 1).
Table 1 | Patient population demographics with mean values.
Characteristics N (%)
CHARACTERISTIC OF PATIENTS
Sex
Female 157 (39)
Male 243 (61)
Pre-hospitalizing
0 296 (74)
1 72 (18)
2 23 (6)
3 7 (2)
4 1 (1)
6 1 (1)
BMI [mean(SD)] 30 (7.5)
Age [mean(SD)] 58 (15.3)
4% 
21% 
75% 
MRSA Posi!ve
MSSA Posi!ve
Nega!ve for SA
FIGURE 1 | Sample prevalence of Staphylococcus aureus.
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Table 2 | Statistical correlations between patient characteristics and
MRSA positivity.
Outcome Characteristics P -value
ASSOCIATION BETWEEN MRSAAND PATIENT CHARACTERISTICS
MRSA Age 0.196
Sex 0.959
BMI 0.968
Pre-hospitalizing 0.214
The data were analyzed using Statistical Analysis Software, ver-
sion 9.3 (SAS Institute Inc., Cary, NC, USA). Prior to analysis, the
data were examined for outliers; no extreme values were found.
Descriptive statistics are reported as mean± SE and median
(range) or total number and percentage. Binomial proportions
and confidence intervals were provided for both MRSA and SA
populations. Logistic regression analysis was conducted to deter-
mine the relationship between the main outcome (MRSA) and
the other covariates including age, sex, BMI, and previous hospi-
talization (Table 2). Univariate logistical regression analysis was
performed before multivariable analysis for each of the covari-
ates, which were included in the full model if the covariate was
significant (p< 0.20 at the 0.05 α level) in a two-sided test.
LIMITATIONS
This study was limited by a small sample size from a single insti-
tution of patients from similar geographic origin. Only the nares
were tested for MRSA and SA colonies, which may have allowed for
patients harboring extra-nasal colonies to appear as false-negative.
The confidence intervals MRSA prevalence had a wide margin of
error, suggesting the need for further study.
DISCUSSION
The prevalence of MRSA and SA in patients undergoing preop-
erative assessment for cardiothoracic and neurological surgery in
Columbus, OH was analyzed. There were no significant differences
between MRSA-positive and negative patient outcomes within the
study, and no significant association between MRSA and patient
characteristics was found.
This study provides insight on the extent of MRSA and SA
colonization in a patient population particularly vulnerable to
soft-tissue infection due to body-cavity exposure and extensive
wound healing. In the sample population, 4.25% of patients tested
positive for MRSA and 25.25% tested positive for SA. Confidence
intervals were used to estimate the total population rate of MRSA
and SA. This analysis accounts for the small sample size relative
to the population size of cardiothoracic and neurological surgical
patients.
The 95% confidence interval of MRSA carriers is 2.67–6.7%
of cardiothoracic and neurological surgical patients. Likewise, the
95% confidence interval of SA carriers is 21.24–29.73%.
Compared to several other patient populations, preopera-
tive cardiothoracic and neurological surgical patients have lower
MRSA prevalence and, therefore, may be less likely to intro-
duce community-acquired MRSA into hospitals. Populations with
lower reported MRSA rates include pediatric healthcare workers
and patients, as well as those in outpatient primary care clinics (12,
27, 28). Previous studies have reported cardiothoracic and neuro-
logical surgical patients to be at a lower risk for MRSA colonization
than most other patient demographics including general surgery
patients, emergency ward patients, and nursing home populations
(22). Our study supported these previous reports.
Alone, these rates question the need for preoperative screen-
ing of cardiothoracic and neurological surgical patients. However,
patients undergoing cardiothoracic and neurological surgeries
are at a unique risk of MRSA-related SSIs when compared to
patients undergoing orthopedic, otolaryngologic, gastrointestinal,
and colorectal procedures. If screening criteria include the relative
risk of SSI among MRSA carriers, then patients undergoing car-
diothoracic and neurological surgery may be recommended for
consideration in the development of targeted screening protocols.
CONCLUSION
Improved carrier surveillance is an important aspect of limit-
ing the introduction and transmission of MRSA in healthcare
environments. Targeted screening allows carriers to be treated
and also provides valuable epidemiological data to inform screen-
ing protocols. The current analysis indicates the preoperative
prevalence of MRSA and SA in a sample of cardiothoracic
and neurological surgical patients: 4.25% presented with MRSA
and 25.25% with SA. According to prior studies, cardiotho-
racic and neurological surgical patients are at high risk for
surgical-site infection, making preoperative assessment and treat-
ment of these patients a valuable prevention of postoperative
complications.
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